RNAi method applied to bee colony

By combining pET28-BL21(DE3)RNaseIII-bacterial expression system and nanocarrier SPc, the application of RNAi technology in bee colonies is achieved, solving the problem of low RNAi efficiency in bees, significantly improving RNAi efficiency and stability, and meeting the The demand for field applications has promoted the development of bee colony research.

CN118995827APending Publication Date: 2024-11-22BEE RES INST CHINESE ACAD OF AGRI SCI
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
CN202411112531.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In bee RNAi technology, dsRNA expression is insufficient and RNAi is inefficient, so it cannot be applied to bee populations.

Method used

The pET28-BL21(DE3)RNaseIII-bacterial expression system was used to combine with the nanocarrier star polycation (SPc), and RNAi was implemented under natural conditions through an automatic feeding device to improve the efficiency of bee RNAi.

Benefits of technology

RNAi was successfully realized in bee colonies, significantly inhibiting target gene expression, improving the efficiency and stability of RNAi, reducing costs, meeting the needs of field applications, and promoting the development of bee colony research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118995827A_ABST
    Figure CN118995827A_ABST
Patent Text Reader

Abstract

The invention discloses an RNAi (Ribonucleic Acid Interference) method applied to a bee colony, which comprises the following specific steps: S1, exploring the diet preference of bees, and determining the influence of feeding escherichia coli on the bees; s2, exploring the protectiveness of the nano material SPc on dseGFP expressed by an escherichia coli pET28-BL21 (DE3) RNase III-system under the action of intestinal fluid of bees, wherein the dseGFP is expressed by the escherichia coli pET28-BL21 (DE3) RNase III-system; s3, clearly utilizing the nano material SPc to deliver RNA, so that the efficiency of RNAi of bees can be improved; and S4, delivering dsRNA based on escherichia coli expression and a nano material, and applying RNAi in a bee colony under natural conditions. According to the invention, a low-cost dsRNA synthesis method is established for the application of a bee RNAi technology, the requirements of field RNAi technology application are better met, RNAi experiments are executed in a bee colony under natural conditions, the development of bee colony research taking RNAi as a core is promoted, and reference is provided for RNAi of other insect colonies.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of bioengineering, and in particular to an RNAi method applied to honey bee colonies. Background Art

[0002] Honey bees (Apis mellifera), as the most important pollinator in the world, are of great significance in promoting agricultural production and maintaining ecological balance. Research on honey bee genetic resources, gene functions and social behaviors helps to understand biological gene functions and behavioral mechanisms. RNA interference (RNAi) technology is considered to be an effective tool for studying the gene functions of insect gene silencing, and has received widespread attention in the field of life sciences since its inception. At present, in honey bees, RNAi is only used to study the gene functions of isolated honey bees in the laboratory. Based on the eusociality of honey bees, it is of great significance to explore the key genes and molecular mechanisms related to the production of bee products, environmental adaptability and swarm behavior in the bee colony. However, due to the complexity of RNAi operation, the demand for dsRNA and the uncertainty of the natural environment, RNAi has not been implemented in honey bee colonies.

[0003] At present, the commonly used introduction methods for studying gene function using RNAi are injection and feeding. The injection method is obviously not suitable for field environments, and feeding requires a large amount of dsRNA. Unlike chemical synthesis, the pET28-BL21 (DE3) RNaseIII-bacterial expression system has been proven to be an effective method for expressing dsRNA in large quantities. In addition, dsRNA can be combined with the nanocarrier star polycation (SPc) to carry double-stranded RNA into the insect body through the nanocarrier to achieve the synergistic effect of RNAi. In this way, dsRNA can be mass-produced and RNAi efficiency can be improved. However, there is no such application in honey bee research.

[0004] Based on SPc and pET28-BL21(DE3)RNaseIII-bacterial expression system, we established a method for RNAi in honey bee colonies. After verification in laboratory environment, it was successfully applied to honey bee colonies in small beehives with automatic feeding devices in the wild. This method is the first to use pET28-BL21(DE3)RNaseIII-system to express honey bee dsRNA, and SPc is used to enhance the efficiency of honey bee RNAi, realize RNA interference in honey bee colonies, and expand the scope of honey bee gene research, providing a reference for the application of insect RNAi technology. Summary of the invention

[0005] The purpose of the present invention is to solve the shortcomings of the prior art bee RNAi technology, such as insufficient dsRNA expression, low RNAi efficiency, and inability to be applied to bee colonies, and to propose an RNAi method applied to bee colonies.

[0006] In order to achieve the above object, the present invention adopts the following technical solutions:

[0007] A method for RNAi applied to honey bee colonies, comprising the following specific steps:

[0008] S1: To explore the dietary preferences of honey bees and clarify the effects of feeding E. coli on honey bees;

[0009] S2: To explore the protective effect of nanomaterial SPc on dseGFP expressed by the RNaseIII-system of Escherichia coli pET28-BL21 (DE3) under the action of honey bee intestinal fluid;

[0010] S3: It is clear that using nanomaterials SPc to deliver RNA can improve the efficiency of honey bee RNAi;

[0011] S4: Application of RNAi in bee colonies under natural conditions based on Escherichia coli expression and nanomaterial delivery of dsRNA.

[0012] As a further technical solution of the present invention, the S1 specifically includes the following steps:

[0013] S1a: Apis mellifera was raised as the research object, and each colony was kept as consistent as possible in terms of rearing conditions, colony strength and diet;

[0014] S1b: Collect newly emerged worker bees, raise them in beekeeping cages and place them in a constant temperature and humidity incubator;

[0015] S1c: Cultivate the E. coli solution to OD 600 =1, centrifuge to collect the supernatant and precipitate, redissolve with an equal amount of honey water to obtain a new bacterial solution, one part of which is ultrasonically disrupted, and the other part is not treated;

[0016] S1d: The experimental bees were fed with honey water alone, ultrasonically disrupted bacterial solution, and untreated bacterial solution, and two of the three solutions were also fed to the experimental bees;

[0017] S1e: Record the food consumption of bees 2, 4, 6, 8, and 10 days after treatment and analyze the results.

[0018] As a further technical solution of the present invention, the S2 specifically includes the following steps:

[0019] S2a: After expressing dseGFP using the pET28-BL21 (DE3) RNaseIII-system, 1 μg of dseGFP was mixed with SPc at different mass ratios (16:1, 8:1, 4:1, 2:1, and 1:1), and after standing at room temperature for 15 min, agarose gel electrophoresis was performed;

[0020] S2b: The complete intestine of the honey bee was collected using sterile forceps to obtain the honey bee intestinal fluid stock solution, which was diluted with PBS and mixed with 1 μg dseGFP for agarose gel electrophoresis experiment;

[0021] S2c: 1 μg dseGFP, a mixture of 1 μg dseGFP and 250 ng SPc (4:1), a mixture of 1 μg dseGFP and 50% intestinal fluid, and a mixture of 1 μg dseGFP, SPc and 50% intestinal fluid were subjected to agarose gel electrophoresis, and the band brightness was analyzed.

[0022] As a further technical solution of the present invention, in S2b, the specific operation is: use sterile tweezers to collect the complete intestines of approximately 30 bees into a clean 1.5mL centrifuge tube, use an ultrasonic grinder (50 Hz, 30 seconds) to thoroughly grind, use a low-temperature centrifuge to centrifuge (12000r, 5min), take the supernatant as the intestinal fluid stock solution for the experiment, dilute the intestinal fluid to 100%, 75%, 50%, 25%, 12.5%, 6.25% and 3.125% with 1x PBS, and mix it with 1μg dseGFP to a final concentration of 50ng / μL, and store it at room temperature for 1.5h before performing agarose gel electrophoresis experiment.

[0023] As a further technical solution of the present invention, the S3 specifically includes the following steps:

[0024] S3a: Defensin (DEF) and inhibitor of apoptosis (IAP) genes were selected as target genes for RNAi experiments, and dsDEF and dsIAP were expressed using the pET28-BL21 (DE3) RNaseIII-system;

[0025] S3b: The bacterial solution obtained in the previous step was centrifuged at 10000r for 1 min, the supernatant was discarded, the precipitate was resuspended with honey water at a fixed ratio, and then disrupted with an ultrasonic disruptor (bar 6, start 2s, stop 3s, 60% power, 30min) to obtain dsDEF and dsIAP released from E. coli. This step was repeated until the bacteria were completely disrupted;

[0026] S3c: The dsRNA, SPc, ultrasonically disrupted E. coli without plasmid transfer, and dseGFP obtained in the previous step were fed to honey bees respectively, and the honey bees fed with honey water and dseGFP served as the control group;

[0027] S3d: The expression levels of dsDEF and dsIAP genes in honey bees were detected on days 2, 4, 6, 8 and 10 after treatment.

[0028] As a further technical solution of the present invention, in S3a, the specific operation of expressing dsDEF and dsIAP using the pET28-BL21 (DE3) RNaseIII- system is as follows: synthesizing 880 bp of DEF and 417 bp of IAP gene fragment sequences respectively, the sequences consisting of a cds region gene sequence, a reverse complementary sequence of the cds region gene sequence and an additional DNA sequence capable of forming a stem-loop structure; cloning the two fragment sequences into plasmid pET-28a, and transforming the recombinant plasmids pET28-DEF and pET28-IAP into Escherichia coli BL21 (DE3) RNase III-, respectively, and expanding the culture; when the OD600 of the bacterial solution reaches about 0.4, adding isopropyl-dd-thiolactoside (IPTG) to induce the expression of dsRNA, and continuing to culture at 37°C for 4 hours to obtain Escherichia coli expressing dsDEF and dsIAP in large quantities.

[0029] As a further technical solution of the present invention, in S3c, the specific operation is as follows: a part of the dsRNA obtained in the previous step is added to SPc at a mass ratio of 4:1, and the other part is not added, and after being kept at room temperature for 15 minutes, they are fed to the bees under the conditions of step S1b respectively; at the same time, the bees are fed with a fixed proportion of honey water, and the ultrasonically disrupted Escherichia coli without plasmid transferred into the honey water and the dseGFP expressed by the pET28-BL21 (DE3) RNaseIII-system diluted with honey water are used as the control group; each treatment is repeated 3 times.

[0030] As a further technical solution of the present invention, in S3d, the specific operation is: on the 2nd, 4th, 6th, 8th and 10th day after treatment, 5 bees are randomly selected each time, and the expression levels of dsDEF and dsIAP genes of the bees are detected by real-time fluorescence quantitative PCR (qRT-PCR); the results show that the expression levels of dsDEF and dsIAP genes of the bees are significantly inhibited in the treatment group, and the RNAi of the SPc group has higher efficiency and longer effective period, indicating that SPc can significantly improve the efficiency of RNAi.

[0031] As a further technical solution of the present invention, the S4 specifically includes the following steps:

[0032] S4a: Under natural conditions, experimental bee colonies were established using small beehives with automatic feeding devices. 200 grams of newly emerged worker bees and queen bees of the same age were transferred to each small beehive. dsDEF, dsIAP and dseGFP delivered by SPc expressed by Escherichia coli were added to the automatic feeding device to feed the bee colonies. The bee colonies fed with honey water and dseGFP served as the control group. Each treatment was repeated 3 times.

[0033] S4b: On the 4th day after treatment, 10 bees were randomly selected from each beehive, and the expression levels of DEF and IAP in these bees were determined by qRT-PCR. The results showed that the expression levels of DEF and IAP in the treatment group were significantly lower than those in the control group, indicating that RNAi technology can be successfully applied to bee colonies under natural conditions.

[0034] The beneficial effects of the present invention are:

[0035] 1. Expressing dsRNA in Escherichia coli is a low-cost synthesis method. The present invention uses honey mixed with dseGFP expressed by the pET28-BL21 (DE3) RNaseIII-system to directly feed the honey bees, and compares it with a method in which Escherichia coli expressing dseGFP mixed with honey is ultrasonically crushed and then fed to the honey bees. It is determined that the honey bees prefer the solution containing the ultrasonically crushed Escherichia coli expressing dseGFP, providing a theoretical basis for the feeding preference of the honey bees.

[0036] 2. Nanomaterials are believed to be able to enhance the stability of dsRNA. The present invention clarifies the optimal mass ratio of dsRNA to SPc and determines the concentration of honey bee intestinal fluid that can completely degrade 1 μg of dsRNA. Ultimately, it is determined that SPc can significantly enhance the stability of dsRNA, providing a theoretical basis for improving the efficiency of RNAi.

[0037] 3. The present invention expresses honey bee dsRNA through the pET28-BL21 (DE3) RNaseIII-system, which greatly reduces the cost, and measures the effect of SPc delivery of dsRNA on the efficiency of honey bee RNAi in a laboratory environment. Finally, it is clear that the use of nanomaterial SPc to deliver RNA can significantly improve the efficiency of honey bee RNAi, providing new ideas for honey bee RNAi technology.

[0038] 4. The present invention uses a small beehive with an automatic feeding device to establish an experimental bee colony under natural conditions, expresses a large amount of honey bee dsRNA through the pET28-BL21 (DE3) RNaseIII-system, and uses SPc for delivery, successfully inhibiting the expression of the target gene, making it possible to use a large amount of dsRNA in the field and interfere with the expression of key honey bee genes, thereby continuing honey bee research and better meeting the needs of field RNAi technology application. At the same time, a low-cost material basis is established for the application of RNAi technology, which will promote the development of honey bee colony research with RNAi as the core. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 Schematic diagram of bee feeding preference in an embodiment of the present invention. HW: honey water; HNUC: honey water containing Escherichia coli without ultrasonic disruption; HUC: honey water containing Escherichia coli after ultrasonic disruption.

[0040] Figure 2 The figure is a schematic diagram of the protective effect of SPc on dsRNAb gel electrophoresis in the embodiment of the present invention. M: Marker; Na: SPc; ds: DseGFP; 16:1, 8:1, 4:1, 2:1 and 1:1 represent the mass ratio of DseGFP to SPc; 0, 3.125, 6.25, 6.25, 12.5, 25.50, 75, 50, 100 represent the concentration of intestinal fluid; ds+Na: a mixture of dseGFP and SPc; ds+50: a mixture of dseGFP and 50% intestinal fluid; ds+Na+50: a mixture of dseGFP, SPc and 50% intestinal fluid.

[0041] Figure 3 The relative expression levels of DEF and IAP genes in the isolated bees after RNAi in the present invention. HUC: a mixture of honey water and E. coli expressing dsRNA after ultrasonic treatment; dseGFP: a mixture of honey water and dseGFP; dsDEF: a mixture of honey water and dsDEF; dsDEF-Na: a mixture of honey water, dsDEF and SPc; dsIAP-Na: a mixture of honey water, dsIAP and SPc.

[0042] Figure 4 It is the relative expression level of DEF and IAP genes in the bee colony after 4 days of RNAi in the embodiment of the present invention.

[0043] Figure 5 The present invention is a flow chart of a method for RNAi applied to honey bee colonies. DETAILED DESCRIPTION

[0044] In order to make the technical means, creative features, objectives and effects achieved by the present invention easy to understand, the present invention is further explained below in conjunction with specific implementation methods.

[0045] Please see attached Figure 1 -Attached Figure 5 , a method for RNAi applied to honey bee colonies, comprising the following specific steps:

[0046] S1: To explore the dietary preferences of honey bees and clarify the effects of feeding E. coli on honey bees;

[0047] S1a: Apis mellifera was raised as the research object, and each colony was kept as consistent as possible in terms of rearing conditions, colony strength and diet;

[0048] S1b: Collect newly emerged worker bees, raise them in beekeeping cages and place them in a constant temperature and humidity incubator;

[0049] S1c: Cultivate the E. coli solution to OD 600 =1, centrifuge to collect the supernatant and precipitate, redissolve with an equal amount of honey water to obtain a new bacterial solution, one part of which is ultrasonically disrupted, and the other part is not treated;

[0050] S1d: The experimental bees were fed with honey water alone, ultrasonically disrupted bacterial solution, and untreated bacterial solution, and two of the three solutions were also fed to the experimental bees;

[0051] S1e: Record the food consumption of bees 2, 4, 6, 8, and 10 days after treatment and analyze the results.

[0052] Statistical analysis results showed that there was no difference in food consumption among groups of bees fed the three ingredients individually; however, when the same group of bees were fed two of the solutions at the same time, the bees preferred honey water or the bacterial solution treated with ultrasonication to the bacterial solution not treated with ultrasonication.

[0053] S2: To explore the protective effect of nanomaterial SPc on dseGFP expressed by the RNaseIII-system of Escherichia coli pET28-BL21 (DE3) under the action of honey bee intestinal fluid;

[0054] S2a: After expressing dseGFP using the pET28-BL21 (DE3) RNaseIII-system, 1 μg of dseGFP was mixed with SPc at different mass ratios (16:1, 8:1, 4:1, 2:1, and 1:1), and after standing at room temperature for 15 min, agarose gel electrophoresis was performed;

[0055] Finally, it was determined that the optimal mass ratio of dseGFP to SPc was 4:1;

[0056] S2b: Use sterile forceps to collect the complete intestines of about 30 bees into a clean 1.5 mL centrifuge tube, grind thoroughly using an ultrasonic grinder (50 Hz, 30 seconds), centrifuge using a low-temperature centrifuge (12000r, 5min), take the supernatant as the intestinal fluid stock solution for the experiment, dilute the intestinal fluid with 1x PBS to 100%, 75%, 50%, 25%, 12.5%, 6.25% and 3.125%, and mix with 1 μg dseGFP to a final concentration of 50 ng / μL, store at room temperature for 1.5h before performing agarose gel electrophoresis experiments;

[0057] Finally, it was determined that intestinal fluid with a concentration above 50% could completely degrade 1 μg of dseGFP;

[0058] S2c: 1 μg dseGFP, a mixture of 1 μg dseGFP and 250 ng SPc (4:1), a mixture of 1 μg dseGFP and 50% intestinal fluid, and a mixture of 1 μg dseGFP, SPc and 50% intestinal fluid were subjected to agarose gel electrophoresis, and the band brightness was analyzed.

[0059] The results showed that SPc could effectively protect dseGFP from degradation in honey bee intestinal fluid.

[0060] S3: It is clear that using nanomaterials SPc to deliver RNA can improve the efficiency of honey bee RNAi;

[0061] S3a: Defensin (DEF) and inhibitor of apoptosis (IAP) genes were selected as target genes for RNAi experiments. dsDEF and dsIAP were expressed using the pET28-BL21 (DE3) RNaseIII- system. 880 bp of DEF and 417 bp of IAP gene fragment sequences were synthesized, respectively. The sequences consisted of a cds region gene sequence, a reverse complementary sequence of the cds region gene sequence, and an additional DNA sequence that could form a stem-loop structure. The two fragment sequences were cloned into the plasmid pET-28a, and the recombinant plasmids pET28-DEF and pET28-IAP were transformed into Escherichia coli BL21 (DE3) RNase III-, respectively, and cultured. When the OD600 of the bacterial solution reached about 0.4, isopropyl-dd-thiolactoside (IPTG) was added to induce the expression of dsRNA. After continuing to culture at 37°C for 4 hours, Escherichia coli expressing dsDEF and dsIAP in large quantities were obtained.

[0062] S3b: The bacterial solution obtained in the previous step was centrifuged at 10000r for 1 min, the supernatant was discarded, the precipitate was resuspended with honey water at a fixed ratio, and then disrupted with an ultrasonic disruptor (bar 6, start 2s, stop 3s, 60% power, 30min) to obtain dsDEF and dsIAP released from E. coli. This step was repeated until the bacteria were completely disrupted;

[0063] S3c: A portion of the dsRNA obtained in the previous step was added to SPc at a mass ratio of 4:1, while the other portion was not added. After being kept at room temperature for 15 minutes, the mixture was fed to the bees under the conditions of step S1b. At the same time, the bees were fed with honey water at a fixed ratio, and the ultrasonically disrupted Escherichia coli without plasmid transfer diluted in the honey water and dseGFP expressed by the pET28-BL21 (DE3) RNaseIII-system diluted in the honey water were used as the control group. Each treatment was repeated 3 times.

[0064] S3d: On the 2nd, 4th, 6th, 8th and 10th days after treatment, 5 bees were randomly selected each time, and the expression levels of dsDEF and dsIAP genes in bees were detected by real-time fluorescence quantitative PCR (qRT-PCR); the results showed that the expression levels of dsDEF and dsIAP genes in bees were significantly inhibited in the treatment group, and the RNAi in the SPc group had higher efficiency and longer effective period, indicating that SPc can significantly improve the efficiency of RNAi.

[0065] S4: Application of RNAi in bee colonies under natural conditions based on E. coli expression and nanomaterial delivery of dsRNA;

[0066] S4a: Under natural conditions, experimental bee colonies were established using small beehives with automatic feeding devices. 200 grams of newly emerged worker bees and queen bees of the same age were transferred to each small beehive. dsDEF, dsIAP and dseGFP delivered by SPc expressed by Escherichia coli were added to the automatic feeding device to feed the bee colonies. The bee colonies fed with honey water and dseGFP served as the control group. Each treatment was repeated 3 times.

[0067] S4b: On the 4th day after treatment, 10 bees were randomly selected from each beehive, and the expression levels of DEF and IAP in these bees were determined by qRT-PCR. The results showed that the expression levels of DEF and IAP in the treatment group were significantly lower than those in the control group, indicating that RNAi technology can be successfully applied to bee colonies under natural conditions.

[0068] From the above description, it can be seen that the above embodiments of the present invention achieve the following technical effects: by feeding honey water with different components to bees, it is clear that bees have a preference for ultrasonically broken Escherichia coli, by treating the SPc and dsRNA complex through bee intestinal fluid, it is found that the use of SPc can enhance the stability of dsRNA, by feeding isolated bees dsRNA or a complex of dsRNA and SPc in the laboratory, it is found that SPc can significantly improve the efficiency of RNAi, and finally based on Escherichia coli expression and SPc delivery of dsRNA, bee colony RNAi is successfully implemented under natural conditions, making it possible to use dsRNA in large quantities in the field for scientific research, and at the same time, a low-cost dsRNA synthesis method is established for the application of bee RNAi technology, which will promote the development of bee colony research with RNAi as the core.

[0069] A low-cost dsRNA synthesis method has been established for the application of bee RNAi technology, which better meets the needs of field RNAi technology applications, realizes RNAi experiments in bee colonies under natural conditions, promotes the development of bee colony research centered on RNAi, and also provides a reference for colony RNAi of other insects.

[0070] Those skilled in the art should understand that the discussion of any of the above embodiments is merely illustrative and is not intended to imply that the scope of the present invention (including the claims) is limited to these examples. Under the concept of the present invention, the technical features in the above embodiments or different embodiments may be combined, the steps may be implemented in any order, and there are many other variations of the different aspects of the present invention as described above, which are not provided in detail for the sake of simplicity.

[0071] The present invention is intended to cover all such substitutions, modifications and variations that fall within the broad scope of the claims. Therefore, any omissions, modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. A method for RNAi applied to honey bee colonies, characterized in that: The specific steps include: S1: To explore the dietary preferences of honey bees and clarify the effects of feeding E. coli on honey bees; S2: To explore the protective effect of nanomaterial SPc on dseGFP expressed by the RNaseIII-system of Escherichia coli pET28-BL21 (DE3) under the action of honey bee intestinal fluid; S3: It is clear that using nanomaterials SPc to deliver RNA can improve the efficiency of honey bee RNAi; S4: Application of RNAi in bee colonies under natural conditions based on Escherichia coli expression and nanomaterial delivery of dsRNA.

2. The method for RNAi applied to honey bee colonies according to claim 1, characterized in that: The S1 specifically includes the following steps: S1a: Apis mellifera was raised as the research object, and each colony was kept as consistent as possible in terms of rearing conditions, colony strength and diet; S1b: Collect newly emerged worker bees, raise them in beekeeping cages and place them in a constant temperature and humidity incubator; S1c: Cultivate the E. coli solution to OD 600 =1, centrifuge to collect the supernatant and precipitate, redissolve with an equal amount of honey water to obtain a new bacterial solution, one part of which is ultrasonically disrupted, and the other part is not treated; S1d: The experimental bees were fed with honey water alone, ultrasonically disrupted bacterial solution, and untreated bacterial solution, and two of the three solutions were also fed to the experimental bees; S1e: Record the food consumption of bees 2, 4, 6, 8, and 10 days after treatment and analyze the results.

3. The method for RNAi applied to honey bee colonies according to claim 1, characterized in that: The S2 specifically includes the following steps: S2a: After expressing dseGFP using the pET28-BL21 (DE3) RNaseIII-system, 1 μg of dseGFP was mixed with SPc at different mass ratios (16:1, 8:1, 4:1, 2:1, and 1:1), and after standing at room temperature for 15 min, agarose gel electrophoresis was performed; S2b: The complete intestine of the honey bee was collected using sterile forceps to obtain the honey bee intestinal fluid stock solution, which was diluted with PBS and mixed with 1 μg dseGFP for agarose gel electrophoresis experiment; S2c: 1 μg dseGFP, a mixture of 1 μg dseGFP and 250 ng SPc (4:1), a mixture of 1 μg dseGFP and 50% intestinal fluid, and a mixture of 1 μg dseGFP, SPc and 50% intestinal fluid were subjected to agarose gel electrophoresis, and the band brightness was analyzed.

4. The method for RNAi applied to honey bee colonies according to claim 3, characterized in that: In the S2b, the specific operation is: use sterile tweezers to collect the complete intestines of approximately 30 bees into a clean 1.5 mL centrifuge tube, use an ultrasonic grinder (50 Hz, 30 seconds) to grind thoroughly, use a low-temperature centrifuge to centrifuge (12000r, 5min), take the supernatant as the intestinal fluid stock solution for the experiment, dilute the intestinal fluid with 1x PBS to 100%, 75%, 50%, 25%, 12.5%, 6.25% and 3.125%, and mix with 1 μg dseGFP to a final concentration of 50 ng / μL, and store at room temperature for 1.5 hours before performing agarose gel electrophoresis experiments.

5. The method for RNAi applied to honey bee colonies according to claim 1, characterized in that: The S3 specifically includes the following steps: S3a: Defensin (DEF) and inhibitor of apoptosis (IAP) genes were selected as target genes for RNAi experiments, and dsDEF and dsIAP were expressed using the pET28-BL21 (DE3) RNaseIII-system; S3b: The bacterial solution obtained in the previous step was centrifuged at 10000r for 1 min, the supernatant was discarded, the precipitate was resuspended with honey water at a fixed ratio, and then disrupted with an ultrasonic disruptor (bar 6, start 2s, stop 3s, 60% power, 30min) to obtain dsDEF and dsIAP released from E. coli. This step was repeated until the bacteria were completely disrupted; S3c: The dsRNA, SPc, ultrasonically disrupted E. coli without plasmid transfer, and dseGFP obtained in the previous step were fed to honey bees respectively, and the honey bees fed with honey water and dseGFP served as the control group; S3d: The expression levels of dsDEF and dsIAP genes in honey bees were detected on days 2, 4, 6, 8 and 10 after treatment.

6. The method for RNAi applied to honey bee colonies according to claim 5, characterized in that: In the S3a, the specific operation of expressing dsDEF and dsIAP using the pET28-BL21 (DE3) RNaseIII- system is as follows: 880 bp of DEF and 417 bp of IAP gene fragment sequences are synthesized respectively, and the sequences consist of a cds region gene sequence, a reverse complementary sequence of the cds region gene sequence and an additional DNA sequence capable of forming a stem-loop structure; the two fragment sequences are cloned into the plasmid pET-28a, and the recombinant plasmids pET28-DEF and pET28-IAP are respectively transformed into Escherichia coli BL21 (DE3) RNase III-, and expanded and cultured; when the OD600 of the bacterial solution reaches about 0.4, isopropyl-dd-thiolactoside (IPTG) is added to induce the expression of dsRNA, and the Escherichia coli expressing dsDEF and dsIAP respectively in large quantities is obtained after continuing to culture at 37°C for 4 hours.

7. The method for RNAi applied to honey bee colonies according to claim 5, characterized in that: In the S3c, the specific operation is as follows: a part of the dsRNA obtained in the previous step is added to SPc at a mass ratio of 4:1, and the other part is not added, and after keeping at room temperature for 15 minutes, they are fed to the bees under the conditions of step S1b respectively; at the same time, the bees are fed with a fixed proportion of honey water, and the ultrasonically disrupted Escherichia coli without plasmid transferred into the honey water and the dseGFP expressed by the pET28-BL21 (DE3) RNaseIII-system diluted with honey water are used as the control group; each treatment is repeated 3 times.

8. The method for RNAi applied to honey bee colonies according to claim 5, characterized in that: In the S3d, the specific operation is: on the 2nd, 4th, 6th, 8th and 10th day after treatment, 5 bees are randomly selected each time, and the expression levels of dsDEF and dsIAP genes of the bees are detected by real-time fluorescence quantitative PCR (qRT-PCR); the results show that the expression levels of dsDEF and dsIAP genes of the bees are significantly inhibited in the treatment group, and the RNAi of the SPc group has higher efficiency and longer effective period, indicating that SPc can significantly improve the efficiency of RNAi.

9. The method for RNAi applied to honey bee colonies according to claim 1, characterized in that: The S4 specifically includes the following steps: S4a: Under natural conditions, experimental bee colonies were established using small beehives with automatic feeding devices. 200 grams of newly emerged worker bees and queen bees of the same age were transferred to each small beehive. dsDEF, dsIAP and dseGFP delivered by SPc expressed by Escherichia coli were added to the automatic feeding device to feed the bee colonies. The bee colonies fed with honey water and dseGFP served as the control group. Each treatment was repeated 3 times. S4b: On the 4th day after treatment, 10 bees were randomly selected from each beehive, and the expression levels of DEF and IAP in these bees were determined by qRT-PCR. The results showed that the expression levels of DEF and IAP in the treatment group were significantly lower than those in the control group, indicating that RNAi technology can be successfully applied to bee colonies under natural conditions.

10. Use of the method according to any one of claims 1 to 9 in a honey bee colony.

Citation Information

Patent Citations

  • Gene medicine for treating chinese sacbrood as well as preparation and use methods of gene medicine

    CN112402441A

  • Application of reproductive development related gene E75 in prevention and treatment of bactrocera dorsalis

    CN115927305A

  • RNA (Ribonucleic Acid) preparation for preventing and treating cotton aphid based on GABAergic neural pathway and application of RNA preparation

    CN118406682A

  • Composition for controlling Spodoptera exigua comprising E. coli expressing dsRNA specific to integrin beta 1 subunit of Spodoptera exigua, and method for controlling the larvae of Spodoptera exigua using it

    KR1020170012863A